Adhesion Barrier Market

The global adhesion barrier market size is projected to reach USD 0.9 billion by 2028 from USD 0.7 billion in 2023, at a CAGR of 7.4% during the forecast period. The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. On the other hand, the reluctance towards the usage of adhesion barriers amongst surgeons is expected to restrain the growth of this market during the forecast period. The untapped emerging markets will offer lucrative opportunities to the companies offering in adhesion barrier market.

The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).

To know about the assumptions considered for the study download the pdf brochure

Baxter International (US)

Baxter International is a well-established player in the adhesion barriers market. The company provides Seprafilm, ADEPT and Coseal adhesion prevention products, which are a widely used for laparoscopic surgeries, gynecological surgeries and general/abdominal surgeries. The company was able to offer collaborative products in the biosurgery market due to its most recent acquisition of the Seprafilm product line from Sanofi. The company's substantial market share and its global sales channels in roughly 100 countries will ensure its continued expansion in the adhesion barriers market. The company generates most of its revenue from developed regions such as North America and some European countries.

Johnson & Johnson (US)

Johnson & Johnson (J&J) held the second place in the market for adhesion barriers in 2022 owing to its extensive global distribution network and more than 250 subsidiaries. One of the most popular brands for gynecological surgeries worldwide is the company's product, GYNECARE INTERCEDE. The company's dominance in the global market for adhesion barriers is largely due to of its strong geographic presence, which spans North America, Europe, the Middle East & Africa, and the Asia Pacific.

Becton, Dickinson, and Company (US)

Becton, Dickinson, and Company held the third place in the market for adhesion barriers in 2022. The company provides Phasix ST, Composix Mesh, Ventralex Hernia Patch, Ventralight ST Mesh, Ventrio ST Hernia Patch and Ventralight ST Mesh adhesion prevention products, which are a widely used for laparoscopic surgeries and general/abdominal surgeries. The company has a strong presence in over 50 countries, including Europe, Latin America, Japan, the Asia Pacific, and Canada. BD operates and offers its products through direct sales channels or distributors across the globe.

Related Reports:

Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region- Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]